| Latest Martek Biosciences News Headlines |
| Date | Time | Source | |
| 09/15/2009 | 9:00AM | PRNUS | Martek to Present at Two Upcoming Investor Conferences
COLUMBIA, Md., Sept. 15 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (NASDAQ:MATK) announced today that it will be participating in two upcoming investor conferences. On Monday, September 21, 2009 at 12:30 p.m. EDT, Peter Buzy, Chief Financial Officer, will be presenting at the UBS Global Life Sciences... More...>> |
| 09/10/2009 | 9:45AM | PRNUS | Martek Announces Settlement of Patent Dispute with Capsugel France
Capsugel to Purchase DHA from Martek
COLUMBIA, Md., Sept. 10 /PRNewswire-FirstCall/ -- DHA omega-3 innovator and maker of the life'sDHA(TM) brand, Martek Biosciences Corporation (NASDAQ: MATK), announced today it has resolved a patent dispute with Capsugel France. The resolution follows Martek's November 2008 action... More...>> |
| 09/02/2009 | 4:05PM | PRNUS | Martek Announces Third Quarter 2009 Financial Results
- Record non-infant formula nutritional sales of $10.6 million, increase of 41% over third quarter of 2008 - Record quarterly gross margin of 43.7% - Third quarter total revenues and earnings in line with previously disclosed guidance - Fourth quarter 2009 revenue guidance of $87 million to $92 million - Full fiscal year... More...>> |
| 08/20/2009 | 4:05PM | PRNUS | Martek Signs Sole-Source Supply Agreement with Milk Powder Solutions
COLUMBIA, Md., Aug. 20 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (NASDAQ:MATK) announced today that it has entered into a multi-year, sole-source supply agreement with Milk Powder Solutions, based in Australia. Under the terms of the agreement, Martek will serve as Milk Powder Solutions' exclusive supplier... More...>> |
| 08/19/2009 | 9:00AM | PRNUS | Martek to Announce Third Quarter 2009 Results
COLUMBIA, Md., Aug. 19 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (NASDAQ:MATK) announced that it intends to release the results of its third quarter of fiscal 2009 on September 2, 2009, at approximately 4:00 p.m. Eastern Time (ET). Following the release, at 4:45 p.m. ET Martek will conduct a conference... More...>> |
| 07/28/2009 | 4:05PM | PRNUS | Martek to Present at Upcoming Canaccord Adams Conference
COLUMBIA, Md., July 28 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (NASDAQ:MATK) announced today that it will be presenting at the Canaccord Adams 29th Annual Global Growth Conference which is scheduled to take place August 11-13, 2009 at the InterContinental Boston Hotel in Boston, MA. Steve Dubin, Chief... More...>> |
| 07/17/2009 | 12:20PM | PRNUS | EU Committee Approves New Food Applications for Martek's life'sDHA(TM)
life'sDHA Now Approved for Use in Bakery Products, All Dairy Products, Cereal Bars, Beverages
COLUMBIA, Md., July 17 /PRNewswire-FirstCall/ -- DHA omega-3 innovator and maker of the life'sDHA(TM) brand of DHA, Martek Biosciences (NASDAQ:MATK), announced today that it has received a unanimous positive vote from the Standing... More...>> |
| 07/10/2009 | 4:05PM | PRNUS | Martek to Host Investor Conference Call to Discuss Research Presented at the International Conference on Alzheimer's Disease in
COLUMBIA, Md., July 10 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (NASDAQ:MATK) announced today that it will conduct a conference call for investors to discuss DHA research recently presented at the International Conference on Alzheimer's Disease. The call will take place July 13, 2009, at approximately... More...>> |
| 06/03/2009 | 4:05PM | PRNUS | Martek Announces Second Quarter 2009 Financial Results
-- Record revenues of $92.4 million -- Record non-infant formula nutritional sales of $9.8 million -- Record pre-tax income of $17.1 million -- Earnings per share of $0.33, an increase of 20% over last year's second quarter -- Operating cash flow of $17 million (Year-to-date operating cash flow of $26 million) -- Full fiscal... More...>> |
| 05/29/2009 | 3:45PM | PRNUS | Martek to Present at Upcoming Needham Conference
COLUMBIA, Md., May 29 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (NASDAQ:MATK) announced today that it will be presenting at the 8th Annual Needham Life Sciences Conference which is scheduled to take place June 10-11, 2009 at the New York Palace Hotel in New York City. Peter L. Buzy, Chief Financial Officer... More...>> |
| 05/20/2009 | 9:00AM | PRNUS | Martek to Announce Second Quarter 2009 Results
COLUMBIA, Md., May 20 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (NASDAQ:MATK) announced that it intends to release the results of its second quarter of fiscal 2009 on June 3, 2009, at approximately 4:00 p.m. Eastern Time (ET). Following the release, at 4:45 p.m. ET Martek will conduct a conference call... More...>> |
| 04/01/2009 | 12:15PM | PRNUS | Martek, March of Dimes Partner to Promote Importance of DHA
DHA Omega-3 Fatty Acids are Essential to Health of Pregnant Women and Babies, March of Dimes Says
COLUMBIA, Md., April 1 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (NASDAQ:MATK), announced today that it is partnering with March of Dimes, the nation's leading nonprofit organization for pregnancy and baby... More...>> |
| 03/26/2009 | 3:15PM | PRNUS | Martek and Ragasa Sign Multi-Year Exclusive Supply Agreement
Mexican Product Launch Planned for 2009
COLUMBIA, Md. and MONTERREY, Mexico, March 26 /PRNewswire-FirstCall/ -- DHA omega-3 innovator and maker of the life'sDHA(TM) brand, Martek Biosciences Corporation (NASDAQ:MATK) and Ragasa, one of Mexico's largest providers of raw and refined oil products and maker of Mexico's... More...>> |
| 03/04/2009 | 4:05PM | PRNUS | Martek Announces First Quarter 2009 Financial Results
- Product sales of $84.0 million, a 7% increase over last year's first quarter - Total revenue of $87.4 million, up 5% year-over-year - Record pre-tax income of $15.4 million - Earnings per share of $0.29, an increase of 12% over last year's first quarter - New products launched containing life'sDHA(TM) in a variety of... More...>> |
| 02/17/2009 | 2:00PM | PRNUS | Martek to Announce First Quarter 2009 Results
COLUMBIA, Md., Feb. 17 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (NASDAQ:MATK) announced that it intends to release the results of its first quarter of fiscal 2009 on March 4, 2009, at approximately 4:00 p.m. Eastern Time (ET). Following the release, at 4:45 p.m. ET Martek will conduct a conference call... More...>> |
| 02/03/2009 | 12:37PM | PRNUS | Martek, General Mills Collaborate on Microencapsulation Technology for Food Applications
COLUMBIA, Md., Feb. 3 /PRNewswire/ -- DHA (docosahexaenoic acid) omega-3 innovator and maker of the life'sDHA(TM) brand of DHA, Martek Biosciences announced today that it has entered into a license agreement with General Mills for a patented microencapsulation technology. Microencapsulation is a process widely used... More...>> |
| 01/26/2009 | 9:00AM | PRNUS | New Study: Higher DHA Levels Improve Neurodevelopmental Outcomes in Premature Girls
COLUMBIA, Md., Jan. 26 /PRNewswire-FirstCall/ -- Tripling the level of DHA (docosahexaenoic acid) in the early diet of some of the smallest infants born prematurely improved the neurodevelopment outcome of girls, according to a study published in the January 14, 2009 issue of the Journal of the American Medical Association... More...>> |
| 01/08/2009 | 1:00PM | PRNUS | Martek to Present at 11th Annual ICR XChange
COLUMBIA, Md., Jan. 8 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (NASDAQ:MATK) announced today that it will be presenting at the upcoming 11th Annual ICR XChange investor conference. The conference is being held January 14-15, 2009 at The St. Regis Monarch Beach Resort & Spa in Dana Point, California... More...>> |
| 12/30/2008 | 3:00PM | PRNUS | Martek to Present at Upcoming Needham Conference
COLUMBIA, Md., Dec. 30 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (NASDAQ:MATK) announced today that it will be presenting at the upcoming Needham & Company 11th Annual Growth Conference in New York City. The conference is being held January 6-8, 2009 at the New York Palace Hotel. Peter L. Buzy, CFO... More...>> |
| 12/11/2008 | 4:05PM | PRNUS | Martek Announces Fourth Quarter and FY 2008 Financial Results
- Fourth quarter revenue of $90.4 million, up 10% year-over-year
COLUMBIA, Md., Dec. 11 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (NASDAQ:MATK) today announced its financial results for the fourth quarter and fiscal year ended October 31, 2008. Revenues for the fourth quarter were $90.4 million, up... More...>> |